Mineralys Therapeutics (NASDAQ: MLYS) files Form 144 to sell 4,584 shares

Rhea-AI Filing Summary

Mineralys Therapeutics (MLYS) filed a Form 144 stating an intended sale of 4,584 shares of common stock in a broker assisted cashless exercise related to an exercise of employee stock options on 06/17/2026. The filing lists prior open-market sales by David Rodman from 03/12/2026 through 06/15/2026 with multiple share quantities and dollar amounts.

Insights

Securities Attorney

Notice of intended affiliate sale via Form 144; routine compliance filing.

The filing documents an intended sale of 4,584 shares via a broker assisted cashless exercise on 06/17/2026. Form 144 is a statutory notice required for certain affiliate dispositions; it does not by itself confirm execution.

Prior sales by David Rodman are listed with dates and proceeds through 06/15/2026. Cash‑flow treatment and whether the listed sale executed are not stated in the excerpt; subsequent filings or trade reports would show execution details.

Key Figures

Intended shares to be sold: 4,584 shares Aggregate amount shown (line item): 114600.00 Shares outstanding line (excerpt): 82,498,101 +2 more

5 metrics

Intended shares to be sold 4,584 shares exercise of employee stock options on 06/17/2026

Aggregate amount shown (line item) 114600.00 line entry associated with the 4,584 shares (exact label in excerpt)

Shares outstanding line (excerpt) 82,498,101 appears in same line as securities info with date 06/17/2026

Representative prior sale 6,348 shares sale by David Rodman on 03/12/2026 with proceeds 173,748.15

Most recent prior sale (excerpt) 9,890 shares sale by David Rodman on 06/15/2026 with proceeds 235,487.24

Key Terms

Form 144, broker assisted cashless exercise, exercise of employee stock options

3 terms

Form 144 regulatory

"filed a Form 144 stating an intended sale of 4,584 shares"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

broker assisted cashless exercise financial

"Broker assisted cashless exercise"

exercise of employee stock options financial

"Exercise of employee stock options"

FAQ

What does Mineralys Therapeutics' Form 144 for MLYS report?

The Form 144 reports an intended sale of 4,584 shares via a broker assisted cashless exercise tied to an exercise of employee stock options scheduled on 06/17/2026. It also lists prior sales by David Rodman between March and June 2026.

Who is the selling party listed in the filing for MLYS?

The filing references sales by David Rodman, listing multiple open‑market transactions from 03/12/2026 through 06/15/2026 with specific share counts and dollar amounts shown for each trade.

Does the Form 144 confirm the shares were sold for MLYS?

No. The Form 144 is a notice of an intended affiliate disposition; it indicates the proposed method (broker assisted cashless exercise) and date 06/17/2026 but does not by itself confirm execution or final proceeds.

What prior transactions are listed in the MLYS excerpt?

The excerpt lists multiple prior Common Stock sales by David Rodman, including trades on 03/12/2026, 03/13/2026, and continuing through 06/15/2026, with individual share counts and dollar proceeds shown for each entry.

What method is described for the 06/17/2026 MLYS transaction?

The filing specifies the method as a broker assisted cashless exercise arising from an exercise of employee stock options and lists the security as Common stock with the action dated 06/17/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/17/2026 - 04:20 PM Accepted by SEC EDGAR 06/17/2026 - 04:20 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common stock	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	4584	114600.00	82498101	06/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common stock	06/17/2026	Exercise of employee stock options	Mineralys Therapeutics, Inc.			4584	06/17/2026	Broker assisted cashless exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	03/12/2026	6348	173748.15
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	03/13/2026	14058	369225.07
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	03/17/2026	417	10696.05
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	04/09/2026	2170	59414.60
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	04/13/2026	14058	373086.81
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	04/15/2026	6348	175585.68
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	04/17/2026	416	13033.28
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	05/11/2026	2171	64500.41
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	05/12/2026	6348	186348.35
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	05/13/2026	14056	401789.92
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	05/18/2026	417	11488.35
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	06/10/2026	2170	54250.00
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	06/12/2026	6349	151901.37
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	06/15/2026	9890	235487.24

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)